Can antibiotic treatment failure in tubo-ovarian abscess be predictable?

We aimed to identify factors that would predict the success of antibiotic treatment and the need for surgical treatment in tubo-ovarian abscess (TOA) patients. The data of 146 patients with a diagnosis of TOA were analyzed retrospectively. Patients were separated into two groups; successfully treate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of obstetrics & gynecology and reproductive biology 2021-03, Vol.258, p.253-257
Hauptverfasser: Akselim, Burak, Karaşin, Süleyman Serkan, Demirci, Ahmet, Üstünyurt, Emin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 257
container_issue
container_start_page 253
container_title European journal of obstetrics & gynecology and reproductive biology
container_volume 258
creator Akselim, Burak
Karaşin, Süleyman Serkan
Demirci, Ahmet
Üstünyurt, Emin
description We aimed to identify factors that would predict the success of antibiotic treatment and the need for surgical treatment in tubo-ovarian abscess (TOA) patients. The data of 146 patients with a diagnosis of TOA were analyzed retrospectively. Patients were separated into two groups; successfully treated with antibiotics and going under surgery after antibiotic treatment failure. Demographic, clinical and laboratory data of patients were examined between both groups that could determine the success of treatment. In the surgical treatment group, age, body mass index (BMI), and C-reactive protein (CRP) values ​​were higher than the antibiotic treatment group (p = 0.017, p = 0.026, and p < 0.001 respectively). Patients who underwent surgery had a significantly larger abscess than those who received antibiotic therapy (79.4 ± 21.1 mm vs. 50.9 ± 13.2 mm, p < 0.001). Cut-off values of the findings, which were identified as risk factors in predicting the failure of antibiotic treatment, were found with ROC analyses. This cut-off was 41.5 years for age (sensitivity 71.3 %, specificity 60 %), 26.72 kg/m2 for BMI (sensitivity 51.5 %, specificity 71.1 %), and 143.5 mg/L for CRP value on admission (sensitivity 68.3 %, specificity 71.1 %). The cut-off for abscess diameter was 62.5 mm (sensitivity 88.1 %, specificity 82.2 %). Especially in large tubo-ovarian abscesses, early surgical intervention should be preferred considering the age, BMI, and CRP values.
doi_str_mv 10.1016/j.ejogrb.2021.01.011
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2480264377</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0301211521000233</els_id><sourcerecordid>2480264377</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-6bbaa9e642f3a07d43a56b7c4b959ac3ca826898c9eb7a803a86070555c0d2cf3</originalsourceid><addsrcrecordid>eNp9kEtLw0AQgBdRbK3-A5EcvaTuK5vkokhRKxS86HmZ3UxkS5rU3U3Bf29CqkeHgbl88_oIuWZ0yShTd9slbrtPb5accrakY7ITMmdFztNcZfKUzKmgLOWMZTNyEcKWDiFEeU5mQsiCy6yck_UK2gTa6IzrorNJ9Ahxh21ManBN7zFxbRJ706XdAbwbYRMshpAYTPYeK2cjmAYfLslZDU3Aq2NdkI_np_fVOt28vbyuHjepFYrHVBkDUKKSvBZA80oKyJTJrTRlVoIVFgquirKwJZocCiqgUDSnWZZZWnFbiwW5nebufffVY4h654aDmgZa7PqguSwoV1Lk-YDKCbW-C8Fjrffe7cB_a0b16FBv9eRQjw41HZMNbTfHDb3ZYfXX9CttAO4nAIc_Dw69DtZhawcZHm3UVef-3_ADZg2ENA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2480264377</pqid></control><display><type>article</type><title>Can antibiotic treatment failure in tubo-ovarian abscess be predictable?</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Akselim, Burak ; Karaşin, Süleyman Serkan ; Demirci, Ahmet ; Üstünyurt, Emin</creator><creatorcontrib>Akselim, Burak ; Karaşin, Süleyman Serkan ; Demirci, Ahmet ; Üstünyurt, Emin</creatorcontrib><description>We aimed to identify factors that would predict the success of antibiotic treatment and the need for surgical treatment in tubo-ovarian abscess (TOA) patients. The data of 146 patients with a diagnosis of TOA were analyzed retrospectively. Patients were separated into two groups; successfully treated with antibiotics and going under surgery after antibiotic treatment failure. Demographic, clinical and laboratory data of patients were examined between both groups that could determine the success of treatment. In the surgical treatment group, age, body mass index (BMI), and C-reactive protein (CRP) values ​​were higher than the antibiotic treatment group (p = 0.017, p = 0.026, and p &lt; 0.001 respectively). Patients who underwent surgery had a significantly larger abscess than those who received antibiotic therapy (79.4 ± 21.1 mm vs. 50.9 ± 13.2 mm, p &lt; 0.001). Cut-off values of the findings, which were identified as risk factors in predicting the failure of antibiotic treatment, were found with ROC analyses. This cut-off was 41.5 years for age (sensitivity 71.3 %, specificity 60 %), 26.72 kg/m2 for BMI (sensitivity 51.5 %, specificity 71.1 %), and 143.5 mg/L for CRP value on admission (sensitivity 68.3 %, specificity 71.1 %). The cut-off for abscess diameter was 62.5 mm (sensitivity 88.1 %, specificity 82.2 %). Especially in large tubo-ovarian abscesses, early surgical intervention should be preferred considering the age, BMI, and CRP values.</description><identifier>ISSN: 0301-2115</identifier><identifier>EISSN: 1872-7654</identifier><identifier>DOI: 10.1016/j.ejogrb.2021.01.011</identifier><identifier>PMID: 33482459</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Abscess - drug therapy ; Abscess - surgery ; Abscess size ; Anti-Bacterial Agents - therapeutic use ; Antibiotics ; Fallopian Tube Diseases - drug therapy ; Fallopian Tube Diseases - surgery ; Female ; Humans ; Ovarian Diseases - drug therapy ; Ovarian Diseases - surgery ; Pelvic inflammatory disease ; Pelvic Inflammatory Disease - drug therapy ; Retrospective Studies ; Surgery ; Tubo-ovarian abscess</subject><ispartof>European journal of obstetrics &amp; gynecology and reproductive biology, 2021-03, Vol.258, p.253-257</ispartof><rights>2021 Elsevier B.V.</rights><rights>Copyright © 2021 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-6bbaa9e642f3a07d43a56b7c4b959ac3ca826898c9eb7a803a86070555c0d2cf3</citedby><cites>FETCH-LOGICAL-c362t-6bbaa9e642f3a07d43a56b7c4b959ac3ca826898c9eb7a803a86070555c0d2cf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0301211521000233$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33482459$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Akselim, Burak</creatorcontrib><creatorcontrib>Karaşin, Süleyman Serkan</creatorcontrib><creatorcontrib>Demirci, Ahmet</creatorcontrib><creatorcontrib>Üstünyurt, Emin</creatorcontrib><title>Can antibiotic treatment failure in tubo-ovarian abscess be predictable?</title><title>European journal of obstetrics &amp; gynecology and reproductive biology</title><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><description>We aimed to identify factors that would predict the success of antibiotic treatment and the need for surgical treatment in tubo-ovarian abscess (TOA) patients. The data of 146 patients with a diagnosis of TOA were analyzed retrospectively. Patients were separated into two groups; successfully treated with antibiotics and going under surgery after antibiotic treatment failure. Demographic, clinical and laboratory data of patients were examined between both groups that could determine the success of treatment. In the surgical treatment group, age, body mass index (BMI), and C-reactive protein (CRP) values ​​were higher than the antibiotic treatment group (p = 0.017, p = 0.026, and p &lt; 0.001 respectively). Patients who underwent surgery had a significantly larger abscess than those who received antibiotic therapy (79.4 ± 21.1 mm vs. 50.9 ± 13.2 mm, p &lt; 0.001). Cut-off values of the findings, which were identified as risk factors in predicting the failure of antibiotic treatment, were found with ROC analyses. This cut-off was 41.5 years for age (sensitivity 71.3 %, specificity 60 %), 26.72 kg/m2 for BMI (sensitivity 51.5 %, specificity 71.1 %), and 143.5 mg/L for CRP value on admission (sensitivity 68.3 %, specificity 71.1 %). The cut-off for abscess diameter was 62.5 mm (sensitivity 88.1 %, specificity 82.2 %). Especially in large tubo-ovarian abscesses, early surgical intervention should be preferred considering the age, BMI, and CRP values.</description><subject>Abscess - drug therapy</subject><subject>Abscess - surgery</subject><subject>Abscess size</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Fallopian Tube Diseases - drug therapy</subject><subject>Fallopian Tube Diseases - surgery</subject><subject>Female</subject><subject>Humans</subject><subject>Ovarian Diseases - drug therapy</subject><subject>Ovarian Diseases - surgery</subject><subject>Pelvic inflammatory disease</subject><subject>Pelvic Inflammatory Disease - drug therapy</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><subject>Tubo-ovarian abscess</subject><issn>0301-2115</issn><issn>1872-7654</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLw0AQgBdRbK3-A5EcvaTuK5vkokhRKxS86HmZ3UxkS5rU3U3Bf29CqkeHgbl88_oIuWZ0yShTd9slbrtPb5accrakY7ITMmdFztNcZfKUzKmgLOWMZTNyEcKWDiFEeU5mQsiCy6yck_UK2gTa6IzrorNJ9Ahxh21ManBN7zFxbRJ706XdAbwbYRMshpAYTPYeK2cjmAYfLslZDU3Aq2NdkI_np_fVOt28vbyuHjepFYrHVBkDUKKSvBZA80oKyJTJrTRlVoIVFgquirKwJZocCiqgUDSnWZZZWnFbiwW5nebufffVY4h654aDmgZa7PqguSwoV1Lk-YDKCbW-C8Fjrffe7cB_a0b16FBv9eRQjw41HZMNbTfHDb3ZYfXX9CttAO4nAIc_Dw69DtZhawcZHm3UVef-3_ADZg2ENA</recordid><startdate>202103</startdate><enddate>202103</enddate><creator>Akselim, Burak</creator><creator>Karaşin, Süleyman Serkan</creator><creator>Demirci, Ahmet</creator><creator>Üstünyurt, Emin</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202103</creationdate><title>Can antibiotic treatment failure in tubo-ovarian abscess be predictable?</title><author>Akselim, Burak ; Karaşin, Süleyman Serkan ; Demirci, Ahmet ; Üstünyurt, Emin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-6bbaa9e642f3a07d43a56b7c4b959ac3ca826898c9eb7a803a86070555c0d2cf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Abscess - drug therapy</topic><topic>Abscess - surgery</topic><topic>Abscess size</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Fallopian Tube Diseases - drug therapy</topic><topic>Fallopian Tube Diseases - surgery</topic><topic>Female</topic><topic>Humans</topic><topic>Ovarian Diseases - drug therapy</topic><topic>Ovarian Diseases - surgery</topic><topic>Pelvic inflammatory disease</topic><topic>Pelvic Inflammatory Disease - drug therapy</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><topic>Tubo-ovarian abscess</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Akselim, Burak</creatorcontrib><creatorcontrib>Karaşin, Süleyman Serkan</creatorcontrib><creatorcontrib>Demirci, Ahmet</creatorcontrib><creatorcontrib>Üstünyurt, Emin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of obstetrics &amp; gynecology and reproductive biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Akselim, Burak</au><au>Karaşin, Süleyman Serkan</au><au>Demirci, Ahmet</au><au>Üstünyurt, Emin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Can antibiotic treatment failure in tubo-ovarian abscess be predictable?</atitle><jtitle>European journal of obstetrics &amp; gynecology and reproductive biology</jtitle><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><date>2021-03</date><risdate>2021</risdate><volume>258</volume><spage>253</spage><epage>257</epage><pages>253-257</pages><issn>0301-2115</issn><eissn>1872-7654</eissn><abstract>We aimed to identify factors that would predict the success of antibiotic treatment and the need for surgical treatment in tubo-ovarian abscess (TOA) patients. The data of 146 patients with a diagnosis of TOA were analyzed retrospectively. Patients were separated into two groups; successfully treated with antibiotics and going under surgery after antibiotic treatment failure. Demographic, clinical and laboratory data of patients were examined between both groups that could determine the success of treatment. In the surgical treatment group, age, body mass index (BMI), and C-reactive protein (CRP) values ​​were higher than the antibiotic treatment group (p = 0.017, p = 0.026, and p &lt; 0.001 respectively). Patients who underwent surgery had a significantly larger abscess than those who received antibiotic therapy (79.4 ± 21.1 mm vs. 50.9 ± 13.2 mm, p &lt; 0.001). Cut-off values of the findings, which were identified as risk factors in predicting the failure of antibiotic treatment, were found with ROC analyses. This cut-off was 41.5 years for age (sensitivity 71.3 %, specificity 60 %), 26.72 kg/m2 for BMI (sensitivity 51.5 %, specificity 71.1 %), and 143.5 mg/L for CRP value on admission (sensitivity 68.3 %, specificity 71.1 %). The cut-off for abscess diameter was 62.5 mm (sensitivity 88.1 %, specificity 82.2 %). Especially in large tubo-ovarian abscesses, early surgical intervention should be preferred considering the age, BMI, and CRP values.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>33482459</pmid><doi>10.1016/j.ejogrb.2021.01.011</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0301-2115
ispartof European journal of obstetrics & gynecology and reproductive biology, 2021-03, Vol.258, p.253-257
issn 0301-2115
1872-7654
language eng
recordid cdi_proquest_miscellaneous_2480264377
source MEDLINE; Elsevier ScienceDirect Journals
subjects Abscess - drug therapy
Abscess - surgery
Abscess size
Anti-Bacterial Agents - therapeutic use
Antibiotics
Fallopian Tube Diseases - drug therapy
Fallopian Tube Diseases - surgery
Female
Humans
Ovarian Diseases - drug therapy
Ovarian Diseases - surgery
Pelvic inflammatory disease
Pelvic Inflammatory Disease - drug therapy
Retrospective Studies
Surgery
Tubo-ovarian abscess
title Can antibiotic treatment failure in tubo-ovarian abscess be predictable?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T05%3A44%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Can%20antibiotic%20treatment%20failure%20in%20tubo-ovarian%20abscess%20be%20predictable?&rft.jtitle=European%20journal%20of%20obstetrics%20&%20gynecology%20and%20reproductive%20biology&rft.au=Akselim,%20Burak&rft.date=2021-03&rft.volume=258&rft.spage=253&rft.epage=257&rft.pages=253-257&rft.issn=0301-2115&rft.eissn=1872-7654&rft_id=info:doi/10.1016/j.ejogrb.2021.01.011&rft_dat=%3Cproquest_cross%3E2480264377%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2480264377&rft_id=info:pmid/33482459&rft_els_id=S0301211521000233&rfr_iscdi=true